Evidence map›Paper›PMID 28419759›Full record

ArticleMicrobiologyOpen2017

Regulation of Burkholderia cenocepacia biofilm formation by RpoN and the c-di-GMP effector BerB.

Mustafa Fazli, Morten Rybtke, Elisabeth Steiner, Elisabeth Weidel, Jens Berthelsen, Julie Groizeleau, Wu Bin, Boo Zhao Zhi, Zhang Yaming, Volkhard Kaever and 4 more

Open access · goldAbstract read
In one paragraph

Article in MicrobiologyOpen, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Role of two RpoN inFrontiers in microbiology · 2023
    Article
  6. Article
  7. Pellicle Biofilm Formation inJournal of bacteriology · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. One gene, multiple ecological strategies: A biofilm regulator is a capacitor for sustainable diversity.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  12. International journal of molecular sciences · 2020
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 4 countries.

Mustafa FazliDepartment of Biology, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.
Morten RybtkeCosterton Biofilm Center, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Elisabeth SteinerDepartment of Plant and Microbial Biology, University of Zurich, Zurich, Switzerland.
Elisabeth WeidelDepartment of Drug Design and Optimization, Helmholtz Institute for Pharmaceutical Research Saarland, Saarbrücken, Germany.
Jens BerthelsenCosterton Biofilm Center, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Julie GroizeleauCosterton Biofilm Center, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Wu BinSchool of Biological Sciences, Nanyang Technological University, Singapore, Singapore.
Boo Zhao ZhiSchool of Biological Sciences, Nanyang Technological University, Singapore, Singapore.
Zhang YamingSchool of Biological Sciences, Nanyang Technological University, Singapore, Singapore.
Volkhard KaeverResearch Core Unit Metabolomics, Institute of Pharmacology, Hannover Medical School, Hannover, Germany.
Michael GivskovCosterton Biofilm Center, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Rolf W HartmannDepartment of Drug Design and Optimization, Helmholtz Institute for Pharmaceutical Research Saarland, Saarbrücken, Germany.
Leo EberlDepartment of Plant and Microbial Biology, University of Zurich, Zurich, Switzerland.
Tim Tolker-NielsenCosterton Biofilm Center, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-9751-474X
University of Copenhagen · DKNanyang Technological University · SGHelmholtz Institute for Pharmaceutical Research Saarland · DEUniversity of Zurich · CHMedizinische Hochschule Hannover · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Knowledge about the molecular mechanisms that are involved in the regulation of biofilm formation is essential for the development of biofilm-control measures. It is well established that the nucleotide second messenger cyclic diguanosine monophosphate (c-di-GMP) is a positive regulator of biofilm formation in many bacteria, but more knowledge about c-di-GMP effectors is needed. We provide evidence that c-di-GMP, the alternative sigma factor RpoN (σ54), and the enhancer-binding protein BerB play a role in biofilm formation of Burkholderia cenocepacia by regulating the production of a biofilm-stabilizing exopolysaccharide. Our findings suggest that BerB binds c-di-GMP, and activates RpoN-dependent transcription of the berA gene coding for a c-di-GMP-responsive transcriptional regulator. An increased level of the BerA protein in turn induces the production of biofilm-stabilizing exopolysaccharide in response to high c-di-GMP levels. Our findings imply that the production of biofilm exopolysaccharide in B. cenocepacia is regulated through a cascade involving two consecutive transcription events that are both activated by c-di-GMP. This type of regulation may allow tight control of the expenditure of cellular resources.

Indexed as

BiofilmsBurkholderia cenocepaciaCyclic GMPGene Expression Regulation, BacterialPolysaccharides, BacterialSigma FactorTranscription Factorsbis(3',5')-cyclic diguanylic acidCyclic GMPPolysaccharides, BacterialRpoN protein, Burkholderia cenocepaciaSigma FactorTranscription FactorsberBBiofilmBurkholderia cenocepaciac-di-GMPrpoN

Identifiers

PMID28419759
PMCPMC5552954
OpenAlexW2606067841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.